Abstract
Aim
The clinico-oncological significance of the distance of rectal cancer from the anal verge is unclear and not well reported. The aim of this study is to assess the influence of the rectal cancer distance from the anal verge on clinical management and long-term outcomes after curative resection in a specialised colorectal cancer unit.
Methods
Prospectively collected data on patients who underwent primary rectal cancer treatment at our unit between January 2005 and December 2010 were analysed. Low rectal cancer (LRC) was defined as tumour < 5 cm from the anal verge on MRI scan. Recurrent cancer, palliative resections, perforated tumours and those requiring total pelvic exenteration were excluded.
Results
Three hundred fifty-nine patients underwent surgery for rectal cancer (226 male/133 female). Of these, 149 (41.5%) patients had low rectal cancer (LRC). Compared to patients with mid/upper rectal cancer (M/URC), patients with low rectal cancers were significantly more likely to receive neo-adjuvant therapy (75.2 vs 38%; p < 0.001), to be associated with lower rate of restorative surgery (15.4 vs 79%; p < 0.001) and to have higher rates of pathological positive circumferential resection margin involvement (14.1 vs 7.1%; p = 0.047). There were however no significant difference in the rates of recurrent disease or survival among the two groups.
Conclusion
Distance of rectal cancer from the anal verge does influence the use of neo-adjuvant treatment and ultimate R0 resection rate. It does not influence loco-regional or systemic recurrence rates.
Similar content being viewed by others
References
Wibe A, Syse A, Anderson E, Tretli S, Myrvold HE, Soreide O. Oncological outcomes after total mesorectal excision for cure for cancer of the low rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum 2004; 47: 48–58.
Marr R, Birbeck K, Garvican J, et al. The modern abdominoperineal excision. The next challenge after total mesorectal excision. Ann Surg 2005; 242: 74–82.
Piso P, Dahlke MH, Mirena P et al. Total mesorectal excision for middle and lower rectal cancer: a single institution experience with 337 consecutive patients. J Surg Oncol 2004; 86: 115–21.
Shihab OC, Brown G, Daniels IR, Heald RJ, Quirke P, Moran BJ. Patients with low rectal cancer treated by abdominoperineal excision have worse tumours and higher involved margin rates compared with patients treated by anterior resection. Dis Colon rectum 2010; 53: 53–6.
W. Chambers, A. Khan, R. Waters, I. Lindsey, B. George, N. Mortensen and C. Cunningham. Examination of outcome following abdominoperineal resection for adenocarcinoma in Oxford. Colorectal Disease 2010; 12: 1192–1197.
Sobin LH, Wittekind C (eds). International Union against Cancer TNM Classification of Malignant Tumours, 5th edition. Hoboken, NJ: Wiley, 1997.
Stephen B. AJCC Cancer staging handbook seventh edition, 2010. 177–183.
Healthcare Quality Improvement Partnership (HQIP). National Bowel Cancer Audit Report 2015 [online]. http://www.hqip.org.uk/resources/national-bowel-cancer-audit-report-2015/ (accessed April 2017).
Healthcare Quality Improvement Partnership (HQIP). National Bowel Cancer Audit Report 2016 [online]. http://www.hqip.org.uk/resources/national-bowel-cancer-audit-report-2016/ (accessed April 2017).
Chiang JM, Hsieh PS, Chen JS, et al. Rectal cancer level significantly affects rates and patterns of distant metastases among rectal cancer patients post curative-intent surgery without neoadjuvant therapy. World Journal of Surgical Oncology 2014; 12:197–204.
I J Adam, M O Mohamdee, I G Martin, N Scott, P J Finan, D Johnston and P Quirke. Role of circumferential resection margin involvement in the local recurrence of rectal cancer. Lancet 1994; 344: 707–11.
Bhangu A, Rasheed S, Brown G, et al. Does rectal cancer height influence the oncological outcome? Colorectal Disease 2014; 16: 801–808.
Keighley M, Pemberton J, Fazio V, Parc R. (1996) Atlas of Colorectal Surgery. Churchill Livingstone, New York.
Iris D Nagtegaal and Phil Quirke. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 2008; 26:303–312.
Hojo K, Koyama Y, Moriya Y. Lymphatic spread and its prognostic value in patients with rectal cancer. Am J Surg 1982; 144:350–4.
Merlino J. Defining the Volume–Quality Debate: Is It the Surgeon, the Center, or the Training? Clinics in Colon and Rectal Surgery. 2007; 20(3):231–236. doi: https://doi.org/10.1055/s-2007-984867.
Rogers SO, Wolf RE, Zaslavsky AM, Wright WE, Ayanian JZ. Relation of Surgeon and Hospital Volume to Processes and Outcomes of Colorectal Cancer Surgery. Annals of Surgery. 2006; 244(6):1003–1011. doi:https://doi.org/10.1097/01.sla.0000231759.10432.a7.
Acknowledgements
Thanks to Alison Massam from the HES and IT Department, St James’ Hospital Leeds, and Edward Bolton from Cancer Registry (NYCRIS), Leeds, UK, for their help in data collection.
Author information
Authors and Affiliations
Contributions
The concept and study design was by IB, RS and MASK. Data was collected and analysed by MASK and ARH. MASK and CWA wrote the manuscript. The manuscript was reviewed and amended by NS, RS and IB. Pathology input was by NS.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Funding Information
None.
Additional information
What Does This Paper Add to the Literature?
Patients with low rectal cancers are significantly more likely to be treated with neo-adjuvant therapy, to be associated with non-restorative surgery and to have a higher incidence of positive circumferential resection margin compared to patients with mid/upper rectal cancers. However, the distance of rectal cancer from anal verge did not impact on the loco-regional or systemic recurrence rates and disease-free survival (DFS) and overall survival (OS).
Rights and permissions
About this article
Cite this article
Khan, M.A.S., Ang, C.W., Hakeem, A.R. et al. The Impact of Tumour Distance From the Anal Verge on Clinical Management and Outcomes in Patients Having a Curative Resection for Rectal Cancer. J Gastrointest Surg 21, 2056–2065 (2017). https://doi.org/10.1007/s11605-017-3581-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-017-3581-0